These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 6423660

  • 21. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
    Zanoboni A, Gibillini M, Cucchi MR, Zanoboni Muciaccia W, Zanussi C.
    J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
    [Abstract] [Full Text] [Related]

  • 22. Effect of intravenous administration of growth hormone-releasing factor (hpGRF-44) and Tyr-D-Trp-Ala-Trp-D-Phe-NH2 on plasma hormones and metabolites in goats.
    Hart IC, James S, Perry BN, Simmonds AD.
    J Endocrinol; 1984 Nov; 103(2):173-8. PubMed ID: 6436424
    [Abstract] [Full Text] [Related]

  • 23. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K, Hizuka N, Shizume K, Honda N, Ling NC.
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Stimulation of growth hormone release in dwarf and normal chickens by thyrotrophin releasing hormone (TRH) or human pancreatic growth hormone releasing factor (hpGRF).
    Hoshino S, Suzuki M, Kakegawa T, Wakita M, Kobayashi Y.
    Endocrinol Jpn; 1986 Dec; 33(6):803-11. PubMed ID: 3107966
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Growth hormone response to human pancreatic growth hormone releasing factor in cattle.
    Johke T, Hodate K, Ohashi S, Shiraki M, Sawano S.
    Endocrinol Jpn; 1984 Feb; 31(1):55-61. PubMed ID: 6428865
    [Abstract] [Full Text] [Related]

  • 38. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M, Schopohl J, König A, Müller OA, von Werder K.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M, Ambrosi B, Guglielmino L, Faglia G.
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.